GlassScriptPhysician profile
Sandra Kirkpatrick Thompson
NPI 1679771711
$3,245.76
in general payments reported to CMS, 2019-2025
17 companies · $19.40 in 2025
The $19.40 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,548 · 2022: $1,165 · 2023: $513 · 2025: $19.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.77 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $728.53 | 2021-2023 | Aristada, Lybalvi |
| Sunovion Pharmaceuticals INC. | $661.75 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $445.14 | 2021-2023 | Invega Sustenna, Invega Trinza |
| Abbvie INC. | $350.57 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $233.01 | 2021-2023 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $174.42 | 2021 | |
| Lundbeck LLC | $125.33 | 2021-2023 | Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $116.97 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $115.45 | 2022-2023 | Austedo |
| Vanda Pharmaceuticals INC. | $112.98 | 2021-2023 | Hetlioz, Fanapt |
| Indivior INC. | $84.36 | 2022-2023 | Perseris |
| Noven Therapeutics, LLC | $20.96 | 2021 | |
| Novo Nordisk INC | $19.40 | 2025 | Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.97 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.26 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.52 | 2021 | |
| Eisai INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.